Neuronal calcium-binding protein 1 and -2 (NECAB1/2) localize to multiple excitatory neuron populations in the mouse spinal cord. Here, we analyzed rat and human spinal cord, combining in situ hybridization and immunohistochemistry, complementing newly collated data on mouse spinal cord for direct comparisons. Necab1/2 mRNA transcripts showed complementary distribution in rodent's spinal cord. Multiple-labeling fluorescence histochemistry with neuronal phenotypic markers localized NECAB1 to a dense fiber plexus in the dorsal horn, to neurons mainly in superficial layers and to commissural interneurons in both rodent species. NECAB1-positive (?) motor neurons were only found in mice. NECAB1 distribution in the human spinal cord was similar with the addition of NECAB1-like immunoreactivity surrounding myelinated axons. NECAB2 was mainly present in excitatory synaptic boutons in the dorsal horn of all three species, and often in calbindin-D28k ? neuronal somata. Rodent ependymal cells expressed calbindin-D28k. In humans, they instead were NECAB2 ? and/or calretinin ? . Our results reveal that the association of NECAB2 to excitatory neuronal circuits in the spinal cord is evolutionarily conserved across the mammalian species investigated so far. In contrast, NECAB1 expression is more heterogeneous. Thus, our study suggests that the phenotypic segregation of NECAB1 and -2 to respective excitatory and inhibitory spinal systems can underpin functional modalities in determining the fidelity of synaptic neurotransmission and neuronal responsiveness, and might bear translational relevance to humans.
Introduction
Calcium-binding proteins (CaBPs) can be divided into two subtypes: calcium sensors and calcium buffers (Burgoyne 2007; Schwaller 2010) . One major cluster of CaBPs is T. Harkany and T. Hökfelt shared senior authorship.
Electronic supplementary material The online version of this article (doi:10.1007/s00429-016-1191-3) contains supplementary material, which is available to authorized users. within the EF-hand super-family whose members have variable repeats of conserved EF-hand motifs (Burgoyne 2007; Girard et al. 2015) . For example, parvalbumin is a prototypic EF-hand calcium buffer which became prominent, particularly since it is a selective marker for GABA neurons in the central nervous system (Celio 1990; Antal et al. 1991; Andressen et al. 1993; Freund and Buzsaki 1996; Klausberger and Somogyi 2008) . On the other hand, NCS-1 (neuronal Ca 2? sensor-1), downstream regulatory element antagonistic modulator (DREAM) and secretagogin are calcium sensors with EF-hand motifs. They are, for example, present in primary somatosensory systems and likely involved in pain modulation (Cheng et al. 2002; Averill et al. 2004; Shi et al. 2012) . However, there are still many predicted yet unstudied EF-hand CaBPs in the nervous system. Particularly, the dorsal root ganglia (DRGs) and spinal cord provide vast territories for future systemslevel discoveries given the many modalities of neurons involved in sensory signaling.
Neuronal calcium-binding protein 1 and -2 (NECAB1 and -2) are CaBPs given their two N-terminal EF-hand motifs. NECAB1/2 were originally described as interacting targets for the presynaptic calcium sensor synaptotagmin I, as well as a down-stream target of Pax6 involved in the development of the mammalian retinal primordium, respectively (Bernier et al. 2001; Sugita et al. 2002; Sugita and Sudhof 2000) . NECAB1-like immunoreactivity (LI) is, in the mouse brain, mainly restricted to subsets of neurons positioned distinctly in, e.g. layer 4 of the neocortex, striatum, hilus of the dentate gyrus, a wedge of pyramidal neurons in the CA2 subfield of the hippocampus, as well as subsets of thalamic, especially midline nuclei (e.g. mediodorsal, central medial, paraventricular and reuniens nuclei). NECAB1 expression was also found in the temporal lobe of the human brain (Wu et al. 2007) . A recent in situ hybridization (ISH) study reported that NECAB1 mRNA ? neurons are scattered throughout the mouse hippocampus, whereas the NECAB2 transcript is strongly expressed in CA2 pyramidal neurons (Zimmermann et al. 2013) .
Both Necab1 and Necab2 mRNA transcripts are present in mouse DRG neurons, as shown by single-cell RNA sequencing (Usoskin et al. 2015; Li et al. 2015) . Furthermore, NECAB2 is an identity marker for the subpopulation of neurofilament-containing DRG neurons and co-localizes with tyrosine kinase B receptor (Usoskin et al. 2015) . Finally, a complete overview of the distribution of both two Necab transcripts in mouse brain and spinal cord is found in the Allen Brain Atlas based on digoxigenin labeled probes (Lein et al. 2007; Henry and Hohmann 2012) .
During the past years, we have studied NECAB1/2 distribution at the spinal level. Our first report phenotyped DRG neurons and spinal cord in mouse , allowing comparison with the published unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing (Usoskin et al. 2015; Li et al. 2015) and the Allen Brain Atlas (Henry and Hohmann 2012) . This study shows that both NECAB1/2 proteins are highly enriched in mouse DRG neurons, which mainly belong to the small and medium-sized populations. Moreover, in the spinal dorsal horn NECAB1/2 are to a large extent localized to glutamatergic excitatory interneurons.
The present study deals with NECAB1/2 mRNA and protein distribution in the rat and human spinal cord, which were analyzed on a backdrop of mouse data to provide direct comparisons. Yet we significantly extended this analysis by providing in situ hybridization (ISH) for both NECABs in all three species. We characterized NECAB1/2 neurons by ubiquitous, prototypic synapse markers, such as boutons (synaptophysin) (Wiedenmann and Franke 1985; Rehm et al. 1986; Navone et al. 1986 ), inhibitory systems (GAD67) (Erlander and Tobin 1991) , excitatory neurotransmission (VGLUT1, VGLUT2) (Fremeau et al. 2004; Li et al. 2003; Kaneko et al. 2002) and protein kinase PKCc (PKCc) (Malmberg et al. 1997; Polgar et al. 1999; Mori et al. 1990) ; and somatostatin receptor 2A (SST2A) that labels superficial inhibitory interneurons both in mouse, rat and human (Shi et al. 2014; Polgar et al. 2013; Todd et al. 1998a, b) . Finally, co-localization with calbindin-D28k and calretinin, both 'classical' calcium-binding proteins (Andressen et al. 1993) , was also performed.
Materials and methods

Animals and human samples
Wild type male C57BL/6N mice (n = 23, adult, 12-14 weeks of age) and Sprague-Dawley rats (n = 13, adult, 250-300 g) were obtained from SCANBUR AB (Stockholm, Sweden). Mice and rats were kept under standard conditions on a 12/12 h-light/dark cycle with free access to food and water. Experiments complied with the Swedish policy for the use of research animals, and were approved by a local ethical committee (Stockholms Norra djurförsöksetiska nämnd N101/14). Efforts were made to minimize the number of animals used and their suffering throughout. Human spinal cord was obtained from a 48-year-old female subject who consented to and donated her organs for transplantation surgery (Regionala etikprövningsnämnden i Stockholm nämnd N98/035). Human hippocampal tissue was obtained from a 57-yearold male who passed away due to heart insufficiency (postmortem delay *8 h). No neurological symptoms were reported and neuropathological examination excluded vascular or inflammatory lesions, neoplasms, or neurodegenerative diseases. Examination of the human tissue was performed in the frame of KIN-Neurobiobank (molecular neuropathological investigation of neurodegenerative diseases) and approved by the Ethical Committee of the Medical University of Vienna (N396/2011).
Riboprobe synthesis for in situ hybridization
Antisense and sense RNA probes specific for Necab1 and -2 from mouse, rat and human were synthesized using sequence specific primers (Table S1 ). PCR fragments were subcloned into pCRII-TOPO vector (Invitrogen, Carlsbad, CA, USA) with their orientation confirmed by nucleotide sequencing (KIGene, Stockholm, Sweden). After linearization of the ensuing plasmid DNA, antisense and sense riboprobes were transcribed by T7/Sp6 RNA polymerase (Life Technologies, Carlsbad, CA, USA) in the presence of 35 S-UTP (Perkin Elmer, Boston, MA, USA). Unincorporated nucleotides were removed on NucAway spin columns (Life Technologies). Sense probes were used as negative controls.
In situ hybridization
For ISH, mice (n = 5) and rats (n = 6) were deeply anesthetized with sodium pentobarbital (50 mg/kg, i.p., APL, Stockholm, Sweden) and decapitated. Lumbar spinal cord segments were rapidly dissected, frozen on dry ice and sectioned on a CryoStar NX70 cryostat (Thermo Scientific, Walldorf, Germany) at 20-lm thickness. Sections were mounted onto Superfrost Plus microscope slides (VWR International, Leuven, Belgium) and stored at -80°C. ISH was performed as described (Le Maitre et al. 2013) . Briefly, tissue sections were postfixed in 4 % paraformaldehyde (PFA) and then treated with 0.25 % acetic anhydride in 0.1 M triethanolamine (pH 8.0). Sections were then dehydrated in graded alcohol and stored at -20°C. Sections were pre-hybridized using 50 % (vol/ vol) deionized formamide (pH 5), 50 mM Tris-HCl (pH 7.6), 25 mM EDTA (pH 8.0), 20 mM NaCl, 0.25 mg/ml, yeast tRNA and 2.59 Denhardt's solution for 4 h at 55°C followed by hybridization in a humidified chamber overnight (14-16 h at 55°C). Labeled probes were diluted to a final concentration of 1.0 9 10 6 cpm/200 ll in a solution containing 50 % (vol/vol) deionized formamide (pH 5.0), 0.3 M NaCl, 20 mM DTT, 0.5 mg/ml yeast tRNA, 0.1 mg/ ml poly-A-RNA, 10 % (vol/vol) dextran sulfate, and 19 Denhardt's solution. After hybridization, sections were washed twice for 30 min in 19 SSC at 55°C, 1 h in 50 % (vol/vol) formamide/0.59 SSC at 55°C, 15 min in 19 SSC at 55°C, 1 h in RNase A buffer at 37°C, twice for 15 min in 19 SSC at 55°C, dehydrated in an ascending series of ethanol (70, 90, 95, 100 %; 2 min each) and airdried. Sections were first exposed to Kodak Biomax MR film (VWR International) and then dipped in an autoradiographic emulsion (Kodak, Rochester, NY, USA). After an 'individual' exposure time (2 weeks for mouse and rat Necabs and 8 weeks for human Necabs), slides were developed using D19 developer (Kodak) for 3 min and AL4 fixative (Kodak) for 7 min, dried at room temperature (RT, (22) (23) (24) , and then mounted with a medium containing 90 % glycerol/10 % PBS (vol/vol).
Antibodies for immunohistochemistry
This comparative analysis was made possible by antisera cross-reacting with NECABs from the three species. As such, human protein epitope signature tags (PrESTs) showed [97 % identity with rodents ( Fig. 1a ). Anti-NECAB1/2 antibodies were generated by and obtained from Atlas Antibodies AB (Stockholm, Sweden). All antibodies used in this study (Table S2 ) have previously been extensively characterized, except the mouse monoclonal antibody against NECAB1 (same PrEST). However, the results with this monoclonal antibody reveal neural structures identical to those seen with the rabbit polyclonal antibody (Fig. S1 ). Thus, its use was amenable to successful double-labeling experiments.
Immmunohistochemistry
For immunohistochemistry (IHC), mice (n = 10) and rats (n = 5) were deeply anesthetized with sodium pentobarbital and transcardially perfused with 4 % PFA in 0.16 M phosphate buffer (PB) as described previously (Shi et al. 2012) . The lumbar 4 and 5 (L4, L5) segments of the spinal cord were dissected out and post-fixed in the same fixative for 90 min at 4°C, followed by rinsing with 10 % sucrose in 0.1 M PB containing 0.01 % sodium azide (VWR International) and 0.02 % bacitracin (Sigma, St Louis, MO, USA). For the analysis of the human spinal cord, the tissue was immersion-fixed in 4 % PFA for 2 h and rinsed with 10 % sucrose in 0.1 M PB. Tissues were kept in 10 % sucrose solution (0.1 M PB) for at least 48 h at 4°C. All trimmed tissues were embedded in OCT (HistoLab, Gothenburg, Sweden), frozen with liquid carbon dioxide and sectioned on a CryoStar NX70 cryostat (Thermo Scientific) at 20-lm thickness. The sections were mounted onto Superfrost Plus microscope slides (VWR International) and stored at -20°C.
Mounted sections were air-dried at RT for at least 30 min and then incubated with select combinations of primary antibodies (Table S2 ) diluted in phosphate-buffered saline (PBS) containing 0.2 % (wt/vol) BSA (Sigma) and 0.3 % Triton X-100 (Sigma) in a humid chamber at 4°C for 48 h. Immunoreactivities were visualized using the TSA Plus kit (PerkinElmer, Waltham, MA, USA) as previously described (Shi et al. 2012 ). For double-or triple-labeling, we performed double-'TSA Plus' staining (mouse monoclonal NECAB1 antibody combined with rabbit polyclonal PKCc or SSTR2A antibody) or the indirect Coons procedure (Coons 1958 ) alone with mixed primary antibodies (NECAB2/VGLUT1/VGLUT2; NECAB2/VGLUT2/synaptophysin; NECAB2/calretinin/calbindin-D28k). Double-TSA plus staining was a Comparison of human NECAB1-or 2 epitopes with corresponding fragments from rodents. The epitope similarity between human and rodents is more than 97 %. b Western blotting shows specific bands for NECAB1 and NECAB2 in spinal cord lysates from mouse, rat, and separated spinal dorsal and ventral lysates from human. c Lambda phosphatase treatment does not affect the NECAB2 band migration, whereas the bands for phospho-ERK1/2 cannot be detected after treatment. d Western blotting analysis reveals a specific signal (especially the shorter isoform) in eluted fraction of immunoprecipitation (IP) using an antibody against NECAB2 (target) compared to the elution in the control sample, where no antibody was used. Signal detected in the flowthrough of the control sample is comparable to that of the input lysate, while bands about 35 kDa seems to be almost completely precipitated by the target IP. In-gel digestion and LC-MS/ MS analysis of proteins corresponding to signal detected by western blotting lead to the identification of NECAB2 from bands about 35 kDa in the target eluted fraction but not in the control eluted fraction (indicated by green and red rectangles). The protein is presented at least with two unique peptides in both target samples. Numbers of identified spectra, unique peptides and sequence coverage for NECAB2 are also summarized. e-h NECAB1-LI cannot be seen in rat and human spinal dorsal horn by adding 10 -6 M PrEST of NECAB1 to the antibody solution. i-l The NECAB2-LI cannot be detected in rat and human spinal dorsal horn by adding 10 -6 M PrEST of NECAB2 to the antibody solution. Red dash rectangles indicate specific bands for NECAB2 and pERK1/2 in c and d. PrEST protein epitope signature tag. Scale bars 200 lm in e, f, i, j, 500 lm in g, h and 500 lm in k, l performed as per (Brumovsky et al. 2007 ). Others were visualized with a mixture of secondary IgG (H ? L) antibodies conjugated with Alexa Fluor488 (1:100), carbocyanin (Cy)3 or Cy5 (1:150, Jackson ImmunoResearch Laboratories, West Grove, PA, USA) .
Microscopy and image processing
Dark-field images of sections processed for in situ hybridization were captured on a Nikon microscope equipped with a Coolpix 5000 digital camera (Nikon, Tokyo, Japan). Representative photomicrographs of immunohistochemistry were acquired on an LSM700 confocal laser-scanning microscope (Zeiss, Jena, Germany) at 1 airy unit pinhole settings used uniformly for all images . Emission spectra for each dye were limited as follows: DAPI (\480 nm), FITC/Alexa Fluro488 (505-540 nm), Cy3 (560-610 nm) and Cy5 ([640 nm). For co-localization analysis of presumed boutons (NECAB2/VGLUT1/VGLUT2; NECAB2/VGLUT2/ synaptophysin; or NECAB2 with GAD67), images were acquired at 0.5-lm optical thickness with a 409 water objective (NA/1.40). In select cases, projection images were produced after orthogonal scanning (z-stack) using step-intervals of 1.0 lm (40 9 1.0). Images were processed using the ZEN2012 software (Zeiss). Multi-panel figures were assembled in Adobe Photoshop CS6 software (Adobe System, San Jose, CA, USA).
Quantitative morphometry
The boundaries between laminae I, II and III were identified by observing myelin distribution (lack of myelin in lamina II), whereas the border between lamina II outer and inner layers was delineated by PKCc-like immunoreactivity (PKCc-LI, inner layer of lamina II) and of the neuropeptides galanin and calcitonin gene-related peptide (CGRP) (lamina I and outer layer of lamina II) (processed as described above) (Sardella et al. 2011; Hughes et al. 2003; Carlton et al. 1988 ). The laminar scheme of spinal cord was guided by the cytoarchitectonic organization of rat and human spinal cord (Molander et al. 1984; Haines 1987) .
The quantification of co-localization between NECAB1 ? neurons and PKCc ? or SST2A ? interneurons in superficial layers of the spinal dorsal horn performed on randomly acquired images (409 water objective, LSM700) according to the following criteria: laminae I and II of the mouse and rat spinal cord were covered from medial to lateral by 4-8 frames in a tile-scanning protocol (LSM700). We randomly acquired pictures from frames numbered with either odd or even descriptors (random table). Because of difficulties in distinguishing the punctate intracellular labeling of NECAB2 ? in the somata of interneuron from surrounding NECAB2 ? dendrites and boutons, the quantification of co-localization was only calculated as the percentage of PKCc or SST2A expressing NECAB2 in the superficial layer. All co-localization data were expressed as mean ± standard deviation (SD) and transformed into percentages.
Western blotting
For western blotting of NECAB1 and -2, mice (n = 2) and rats (n = 2) were deeply anesthetized with sodium pentobarbital and decapitated. Lumbar spinal cord segments were rapidly dissected, frozen on dry ice and stored at -80°C until use. Human spinal cord was dissected, frozen and stored at -80°C until use. Total protein was extracted from spinal cord by RIPA lysis buffer (50 mM Tris-HCl, pH 7.4, 1 % NP-40, 0.25 % sodium deoxycholate, 150 mM NaCl and 1 mM EDTA) also containing a protease inhibitor cocktail (P8340, Sigma). For phosphorylation modification, spinal cord samples from mice (n = 4) were extracted with RIPA lysis buffer as above and spinal cord samples (n = 2) with RIPA lysis buffer containing phosphatase inhibitors (1 mM NaF and 1 mM Na 3 VO 4 ) as controls. Lambda protein phosphatase treatment performed according to manufacture's instructions (New England Biolabs, Hitchin, UK). Western blotting was performed according to previous published protocols .
Briefly, boiled samples (95°C for 5 min) with loading buffer were separated on 10 % SDS-PAGE gels, transferred onto polyvinylidine fluoride (PVDF) membranes, and blocked with 5 % non-fat dry milk in TBS (Tris-buffered saline) with 0.1 % Tween-20 for 1 h at RT, and incubated with an antibody against NECAB1 or -2 (antirabbit, 1:5000 in 5 % BSA; Atlas Antibodies AB) or phospho-ERK1/2 (Thr202/Tyr204, anti-rabbit, 1:5000 in 5 % BSA; CellSignaling Technology, Danvers, MA, USA) for 48 h at 4°C. After incubation with HRP-conjugated secondary antibodies (1:5000-1:10,000, DAKO, Glostrup, Denmark) and exposed to ECL (GE Healthcare, Buckinghamshire, UK), membranes were scanned on a ChemiDOC TM ? Imaging system (Bio-Rad Laboratories, Hercules, CA, USA). Membranes were stripped and reprobed with anti-GAPDH antibody (anti-rabbit, 1:1000 in 5 % BSA, CellSignaling Technology) used as the loading control.
Immunoprecipitation
Protein G agarose beads (Pierce/Thermo Fisher Scientific, Rockford, IL, USA) were incubated with 1.5 lg antibody against NECAB2 (HPA013998) for 2 h at 4°C. Beads were washed and further incubated with 150 ll human hippocampal lysate (1 lg/ll) for 4 h. Following intense washing, proteins were eluted by incubation with reducing loading buffer (Amersham WB System, GE Healthcare, Uppsala, Sweden) at 95°C for 5 min. To monitor immunoprecipitation (IP) efficiency, a flow-through fraction was collected after the incubation of the tissue lysate with antibody-coupled beads. As control, the above protocol was conducted without antibody. Fractions were separated by SDS-PAGE (Amersham) and probed for NECAB2. Electrophoresis and western blotting were performed according to manufacturer's instructions, similar to the above description of western blotting. Membranes were developed with goat anti-rabbit Cy3-conjugated secondary antibodies (1:1000 in 3 % BSA in TBS, Amersham).
In-gel digestion and LC-MS/MS analysis
Next, we repeated the above immunoprecipitation protocol for NECAB2, including SDS-PAGE. Bands, corresponding to those revealed by immunoreactivity in western blotting, were excised and proteins were in-gel digested with sequencing grade modified Trypsin (Promega, Madison, WI, USA) as reported (Ghafari et al. 2015) .
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was performed on an Ultimate 3000 nano RSLC system (Thermo Fisher Scientific, Sunnyvale, CA, USA) coupled to an amaZon Speed ETD ion trap mass spectrometer (Bruker Daltonics, Bremen, Germany) via a CaptiveSpray ion source. Data were acquired using Hystar 3.2 (Bruker Daltonics). Peptide samples were loaded onto a trap column (300 lm ID 9 5 mm, packed with Acclaim PepMap100 C18, 5 lm, 100A, Thermo Fisher Scientific) at a flow rate of 30 ll/min for 4 min using 0.1 % formic acid (FA). After washing, the peptides were back-flushed to and separated on a 25 cm analytical column packed with C18 reversed phase material (75 lm ID, packed with Acclaim PepMap RSLC C18, 2 lm, 100A, Thermo Fisher Scientific) at a constant flow rate of 300 nl/min. HPLC solvents were 0.1 % FA in water (solvent A) and 0.08 % FA in 80 % acetonitrile (solvent B). Peptides were eluted with a 11 min gradient ranging from 4 to 13 % solvent B, followed by a 85 min gradient from 13 to 35 % solvent B and finally with a 1 min gradient from 35 to 96 % solvent B. Eluted peptides were analyzed in a data-dependent acquisition mode using a collision-induced dissociation method. In each peptide scan, maximum 10 precursor ions were selected for MS 2 above the intensity threshold of 25,000 with the dynamic exclusion of 0.20 min. MS spectra were acquired in positive mode in a scan range of 400-1400 m/ z and the scan range for MS/MS was always scaled to the precursor. SPS tune was set to 900 m/z. ICC target and maximum accumulation time were determined as 400,000 and 50 ms for MS and 500,000 and 100 ms for MS/MS. Isolation width was 2.2 m/z and fragmentation cutoff was set to 20 % with 60 % fragmentation amplitude using the Enhanced SmartFrag option from 80 to 120 % in 30 ms.
Raw data were interpreted using Compass DataAnalysis 4.1 (Bruker Daltonics) and proteins were identified using the Mascot search engine (Matrix Science, London, UK). Spectra were matched against the Swiss-Prot human (Homo sapiens) reference proteome database (as of November 2015; 20,187 entries). The MS/MS ion search parameters were the following: the number of maximum missed cleavages for trypsin was 2; peptide mass tolerance was ±0.35 Da (# 13 C=1) and fragment mass tolerance was ±0.4 Da; carbamidomethylation of cysteine residues and oxidation of methionine residues were determined as fixed and variable modifications, respectively. Significant threshold for matched peptides was given as p \ 0.05. Protein identity was considered as verified, if it was present at least with two unique peptide sequences (Sase et al. 2015) .
Results
Methodological considerations: specificity of NECAB1 and NECAB2 antibodies NECAB1 and -2 are encoded by 13 exons, highly conserved in mouse, rat and human. Our Western blotting results demonstrated a high degree of similarity at the protein level (molecular mass) using lysates from the spinal cord of the three species (Fig. 1b) . NECAB1 was visualized as a single band around 41 kDa uniformly for mouse, rat and human (Fig. 1b) . In contrast, NECAB2 appeared as two bands at around 39 and 43 kDa, corresponding to its two isoforms predicted for mouse and rat. In human spinal cord, NECAB2 was detected as two bands, but with a considerable smaller mass as compared to mouse and rat (Fig. 1b) . Migration difference between rodents and human was not caused by modified phosphorylation (Fig. 1c) . Similarly, a migration shift for NECAB2 also occurred in human hippocampus (Fig. 1d) . Notably, unique peptides fragments identical to amino acid sequences in NECAB2 could be identified by LC-MS/MS from both immunoreactive bands (Fig. 1d; Fig. S2 ). These observations support that, despite their size variation in human tissues, antibodies raised against NECAB2 recognize their predicted cognate target and are thus specific.
Additional adsorption experiments using immunizing peptides (so called PrESTs) as baits showed the lack of NECAB1-and NECAB2-LI in rat and human spinal cord after pre-incubation of the antisera (Fig. 1e-l) , as previously shown for mouse . Moreover, parallel analysis with mouse monoclonal and rabbit polyclonal anti-NECAB1 antibodies in human spinal cord revealed similar results (Fig. S1) .
In ISH studies, none of the labeling with antisense riboprobes was seen after hybridization with sense probes (insets in Fig. 2a, g, m, Fig. 2r ; insets in Fig. 5g, m;  Fig. 5r ). Thus, an apparent precise overlap between ISH and IHC results with regards to cell body localization further support specificity.
Distribution of Necab1 mRNA transcripts
In the mouse spinal cord, the Necab1 mRNA transcripts were extensively expressed in neurons in the first two (superficial) layers, with very few cells in lamina III ( Fig. 2a, b) . Scattered, intensely labeled neurons were also observed in the lateral deep layers (laminae IV and V) ( Fig. 2a, c) . Positive neurons were found in layer X, mainly dorsal to the central canal, and extended laterally ( Fig. 2a,  d, e ). Furthermore, motor neurons in lamina IX of spinal ventral horn were densely labeled ( Fig. 2a, f) . Necab1 in the rat spinal cord showed a similar distribution, with the exception that motor neurons could not be detected ( Fig. 2g-l) . The results from the human spinal cord are less clear (Fig. 2m ). Only single neurons could be identified in the dorsal horn, e.g. in lateral lamina II (Fig. 2n) , and in deep layers (lamina IV/V) ( Fig. 2o) , whereas several distinctly labeled neurons in lamina X surrounded the central canal in the human cord (Fig. 2p, q) .
Distribution of NECAB1 protein
Overall, the cellular distribution of NECAB1 protein was similar to that of the Necab1 mRNA transcript, although being more abundant and distinct in the human spinal cord. Thus, the NECAB1 antiserum intensely labeled neurons and fiber networks in various parts of the spinal cord from both rodents, including the superficial layers, lateral lamina V, lamina X and lamina VII/VIII, as shown in cross sections of spinal cord from mouse and rat (Fig. 3a, f) . Many neurons in the superficial layers were NECAB1 ? (Fig. 3b, g) . Relatively large NECAB1immunoreactive (IR) neurons with long processes were located in lateral lamina V bordering the white matter ( Fig. 3c, h ). There were patches of NECAB1-IR neurons located above the central canal in lamina X (Fig. 3d, i) . In mouse spinal ventral horn, NECAB1-IR commissural interneurons were located in its medial aspects with long processes extending towards the mid-line (Fig. 3e) . Similar NECAB1-IR neurons were also observed in lamina VII/VIII of the rat (Fig. 3j ). However, NECAB1-IR motor neurons were observed in mouse (indicated by dashed magenta circle in Fig. 3a ) but not in rat (Fig. 3f ).
In human spinal cord, the NECAB1 staining was indistinct when viewed at low-power, but a fluorescent band could still be seen in lamina II, as well as evenly distributed small rings, also in the spinal white matter (Figs. 1g, 3k) . At higher resolution, clearly labeled neurons were seen in superficial layers, including neurons in the lateral lamina II (Fig. 3l ), lamina V (Fig. 3m ) and lamina X (Fig. 3n) . Both polyclonal and monoclonal anti-NECAB1 antibodies labeled round structures surrounding myelinated axons; in fact, a fluorescent band of varying thickness could be seen around most axons (Fig. 3o) . Importantly, this, as all other staining, was eliminated by antigen pre-adsorption (Fig. 1g, h) . Taken together, the distribution pattern of NECAB1, both with regards to its mRNA transcript and protein, is similar in mouse and rat, an exception being the lack of NECAB1-IR motor neurons in rat and of periaxonal rings in both rodents species.
NECAB1 co-localization with PKCc or SST2A
SST2A is a conserved neurochemical marker for inhibitory interneurons in the spinal dorsal horn, present both in rodents and human. PKCc is a conserved marker specific for excitatory interneurons in inner layer of lamima II, and also labels the corticospinal tract, the anatomical localization of which however is different between rodents and human ( Fig. S3a-e ). In the mouse, only few (2.5 ± 0.7 %) NECAB1-IR neuron profiles (NPs) were SSTR2A ? . Conversely, 15.3 ± 2.3 % of SSTR2A-IR NPs were NECAB1 ? (Fig. 4a ). In the rat, 11.1 ± 3.5 % of the NECAB1-IR NPs were SSTR2A ? in the superficial layers, and the proportion of SSTR2A-IR neurons expressing NECAB1 was 54.0 ± 7.4 % (Fig. 4b ). Very few NECAB1-IR NPs were PKCc ? in the mouse superficial dorsal horn (1.3 ± 1.0 %) and less than 10 % of the PKCc-IR NPs were NECAB1 ? (6.8 ± 6.7 %), the latter always being weakly labeled (Fig. 4c ). However, in rat 12.1 ± 0.6 % of the NECAB1-IR neurons were PKCc ? and half of the PKCc-IR NPs were NECAB1 ? (55.4 ± 0.7 %), distinctly contrasting mouse (cf. Fig. 4c,  d) . Taken together, mouse and rat show distinct differences with regard to the neurochemical heterogeneity of NECAB1 ? neurons in superficial dorsal horn.
Distribution of Necab2 mRNA transcripts
In mouse spinal cord, Necab2 mRNA transcripts were abundant in inner lamina II (lamina IIi) and extended into lamina III, with only scattered cells in lamina I and outer lamina II (lamina IIo, Fig. 5a, b) . Necab2 mRNA was also detected in the deep layers (Fig. 5a, c) , including lamina X (Fig. 5d ) and the ventral horn (Fig. 5e ), but was excluded from motor neurons (Fig. 5f ). In rat, Necab2 mRNA transcripts were found in all layers (Fig. 5g-l) , including single motor neurons (Fig. 5g, l) . In the human dorsal horn, scattered small, Necab2 mRNA-containing cells were distributed within a narrow band along the border between lamina IIi and lamina III (Fig. 5m, n) , as well as in lamina I and lamina IV (Fig. 5m, o) . In addition, Necab2 mRNA was found in many ependymal cells lining the central canal and in cell bodies surrounding the central canal (lamina X) ( Fig. 5p, q) . Distribution of NECAB2 protein NECAB2 primarily stained bouton-like structures throughout the spinal cord, with neuronal somata more moderately stained in the dorsal horn. Even though this pattern was relatively conserved between rodents and human, particularly in the dorsal horn, key differences exist (Fig. 6a, f, k) : NECAB2-LI showed the strongest signal in lamina IIi in all species. Yet it extended into lamina III in mouse (Fig. 6a, b) , whereas it intruded into lamina I with a sharp border between lamina II and III in rat and human (Fig. 6f, g, k, l) . Bouton (punctate) staining was seen in all species, with highest density in laminae I-II. The boutons were larger in the human spinal cord. In deep spinal layers of rat and human (laminae III-V), distinctly labeled NECAB2-IR neurons were observed, whereas in mouse they were more diffusely distributed (cf. Fig. 6c, d, h, i, m, n) . In the ventral horn, NECAB2-IR punctate staining with different intensity was observed in all species (human [ mouse [ rat) , and some NECAB2-IR neurons occasionally occurred in rat ventral horn (Fig. 6e, j, o) . NECAB2-LI was observed within the human central canal, not seen in either mouse or rat (Fig. 6a, f, k) (see below). In mouse spinal cord, only few (7.5 ± 5.5 %) SSTR2A-IR NPs were NECAB2 ? in the superficial layers (Fig. 7a) . In rat spinal cord, 18.0 ± 7.8 % of the SSTR2A-IR NPs were NECAB2 ? , but they were usually only weakly labeled (Fig. 7b) . In human dorsal horn, only few SSTR2A ? neuronal somata were detected, and none was NECAB2-IR. However, some NECAB2-IR puncta co-localized with SSTR2A ( Fig. 7c) .
Coexistence of NECAB2-IR and GAD67 was not detected in boutons, neither in mouse/rat nor human spinal cord (Fig. 7d-f ). Occasionally, GAD67 ? puncta formed basket-like structures around NECAB2 ? boutons (inset in Fig. 7f ). Only few GAD67-IR cell bodies were detected, but they did not co-localize with NECAB2 in any of the three species. Furthermore, double-labeling experiments showed that most PKCc-IR interneurons were NECAB2 ? in lamina II of mouse (95.4 ± 2.1 %, Fig. 8a) , and this was similar in rat (89.3 ± 1.2 %, Fig. 8b ). However, in human dorsal horn the percentage of NECAB2 ? PKCc-IR NPs was lower (46.9 %, Fig. 8c ).
NECAB2 mainly coexists with VGLUT2 1 in synaptophysin 1 boutons
To further establish that the punctate structures are nerve endings of excitatory nature, we performed triple labeling of NECAB2 with VGLUT1 and -2, or with synaptophysin and VGLUT2. First, a conserved overlapping distribution pattern of VGLUT1 and VGLUT2 was demonstrated in mouse, rat and human ( Fig. S4a-f ). The dense labeling of VGLUT1 (laminae III-IV and spinal ventral horn) and VGLUT2 (lamina I-II, lateral spinal cord of deep layers, and area surrounding central canal) was complementary ( Fig. S4a-f ). In mouse, NECAB2-IR boutons extensively co-localized with VGLUT2, and some of them (NECAB2 ? / VGLUT2 ? ) were also VGLUT1 ? (Fig. 9a, a1-a4) , and many synaptophysin ? (Fig. 9b, b1-b4 ). In rat NECAB2-IR boutons also co-localized with VGLUT2 and rarely with VGLUT1 (Fig. 9c, c1-c4 ); and many of them (NECAB2 ? / VGLUT2 ? ) were also synaptophysin ? (Fig. 9d, d1-d4 ), as in mouse (Fig. 9b4) . In human spinal cord, many VGLUT1-IR boutons were VGLUT2 ? , but NECAB2-LI only co- localized with VGLUT2 ( Fig. 9e, e1-e4 ). Similar to mouse and rat, NECAB2 ? /VGLUT2 ? boutons largely co-localized with synaptophysin ( Fig. 9f, f1-f4 ).
Similar distribution of calretinin, calbindin-D28k and NECAB2 in the dorsal horn Previously, we have described the distribution and co-localization of NECAB2 with calretinin or calbindin-D28k in the mouse dorsal horn . Here, we expanded this analysis to rat and human. The overview of Scale bars 20 lm in a-c, 10 lm in d, e, 10 lm in f calretinin or calbindin-D28k staining in spinal cord from mouse, rat and human shows similar patterns (Fig. 10) , except for the lack of expression for calretinin and calbindin-D28k around the central canal ( Fig. S5a-f ). In mouse, NECAB2-IR neurons in the inner part of lamina II were largely calbindin-D28k ? and some of them also calretinin ? (Fig. 10a, a1-a4) , with a similar distribution pattern of NECAB2 and calbindin-D28k in rat. Both of them extensively labeled the inner part of lamina II, with a clear border between lamina II and III (Fig. 10b) , which was different from that of mouse (Fig. 10a) . In lamina IIi, NECAB2-IR interneurons highly co-localized calbindin-D28k and many of them were also positive for calretinin ( Fig. 10b, b1-b4 ). In human, the distribution of NECAB2 and calbindin-D28k was similar to mouse, possibly even more so with rat ( Fig. 10c ). In human lamina II, NECAB2-IR interneurons extensively co-localized calbindin-D28k and some of them also calretinin ( Fig. 10c , c1-c4).
Calcium-binding proteins in ependymal cells
The expression of calretinin-, calbindin-D28k-and NECAB2-LIs was different in ependymal cells along the central canal. Calbindin-D28k-LI, but not calretinin or NECAB2, was observed in mouse and rat ependymal cells (Fig. 11a, b ). However, a 'switch' was seen in human. Thus, calretinin (sparse) and NECAB2 (abundant) were expressed in human ependymal cells, whereas calbindin-D28k could not be detected (Fig. 11c ). Instead, neurons in lamina X (surrounding the central canal) expressed calretinin, calbindin-D28k and NECAB2 in the human cord (Fig. 11c, c1-c4 ). The counter staining with cresyl violet confirmed structural difference, showing well-organized ependymal cells along the central lumen in rodents and a hypocellular layer mixed with ependymal cells, but without lumen in human ( Fig. 11d-f ).
Discussion
The present results demonstrate an overall anatomical distribution of NECAB1 and -2 in mouse, rat and human spinal cord. A previous study of mouse was entirely based on immunohistochemistry ), but here we, in addition to throughout newly acquired immunofluorescence images on mouse, include results of the transcripts using ISH, in this way providing further evidence on the specificity of the distribution patterns presented. An important finding is that in all three species NACAB2 is found in nerve endings, that is close to the site of synaptic signaling, a rare feature of CaBPs, including NECAB1.
Similar anatomical distribution but diverse neurochemical profiles for NECAB1
NECAB1 expression in mouse spinal cord, including the commissural interneuron system, is nearly perfectly rerepresented in rat, except for an apparent lack of NECAB1 in motor neurons at both the mRNA and protein levels. The NECAB1 ? commissural interneurons in mouse ) and rat lamina VII/VIII may originate from ventral V3 interneurons. They are primarily located in lamina VIII and act as premotor neurons to synchronize motor outputs (Borowska et al. 2013) . NECAB1 represents a candidate marker for this subset of commissural interneurons involved in coordinating left/right locomotion (Kiehn 2011; Talpalar et al. 2013; Borgius et al. 2014; Birinyi et al. 2003) . The SST2A receptor, a conserved neurochemical marker for inhibitory interneurons in spinal superficial layers (Polgar et al. 2013; Todd et al. 1998b) , is involved in the development of neuropathic pain and itch (Shi et al. 2014; Polgar et al. 2013 ). In our present study, NECAB1 is expressed in half of the rat SST2A ? interneurons, but in mouse only very few SST2A ? interneurons are NECAB1 ? . These observations corroborate our previous findings on the NECAB1 population in mouse having excitatory properties . PKCc labels a small subset of excitatory lamina IIi interneurons involved in pain modulation in both mouse and rat spinal cord. In fact, half of the PKCc ? neurons in rat are NECAB1 ? , contrasting the situation in mouse (only a few, weakly labeled ones were co-localized). Taken together, NECAB1 is in rat expressed both in excitatory and inhibitory neurons in the spinal superficial layers, vs. virtually only in excitatory ones in mouse.
Distribution and conserved excitatory profile of NECAB2
The anatomical distribution of NECAB2 in spinal dorsal horn, especially the strong labeling in lamina IIi, is conserved from rodents to human. However, the Necab2 mRNA transcripts were found across the spinal cord, with a much wider distribution than seen for cell bodies using IHC. This may be due to an underestimation as a consequence of a rapid centrifugal transport of the NECAB2 protein, precluding detection in the neuronal soma. This is a well-known phenomenon in IHC studies on neuropeptides (e.g. Ljungdahl et al. 1978) , and more recently for vesicular glutamate transporters (VGLUTs) (e.g. Hajszan et al. 2004 ) and presynaptic 7-transmembrane receptors (e.g. Stanic et al. 2006 ). An alternative explanation is of course lack of protein translation from pre-existing mRNA. Some differences are encountered at the mRNA level, showing that Necab2 mRNA has a more limited distribution in human than in rodents. However, we still cannot rule out the possibility that also this transcript is widely expressed in human spinal cord, like in rodents, since the sensitivity of the probe may not be optimal and since the quality of the human spinal cord labeling may be casedependent, and of a lower quality compared to rodent spinal cord.
NECAB2 expression in excitatory presynaptic boutons is evidenced by its co-localization with VGLUT1/2 and synaptophysin, but not with GAD67, in all three speciesthe co-localization with VGLUT2 being particularly extensive. VGLUT2 is an accepted and main marker for excitatory glutamatergic interneurons in rodent and human spinal cord (and elsewhere) Oliveira et al. 2003; Malet et al. 2013; Todd et al. 2003; Landry et al. 2004 ). This has also been documented in functional studies, including experiments with knock-out mice, demonstrating the involvement of VGLUT2 in nocifensive behavior and spontaneous and pruritogen-evoked scratching (Scherrer et al. 2010; Lagerstrom et al. 2010; Liu et al. 2010; Moechars et al. 2006) .
NECAB2 in ependymal cells in rodents vs. human
Ependymal cells in the lesioned adult spinal cord are the source of astrocytes and participate in scar formation to inhibit further neuronal degeneration after spinal cord injury (Johansson et al. 1999; Sabelstrom et al. 2013; Lang et al. 2004; Barnabe-Heider et al. 2010) . Earlier work has demonstrated the presence of calbindin-D28k, but not calretinin, in ependymal cells around the rodent central canal (Ren and Ruda 1994) . Here, we confirm these findings and add that rodent ependymal cells do not express either of the two NECABs. However, many ependymal cells located within the human central canal were NECAB2 ? and a small number also calretinin ? /NECAB2negative. Thus, interestingly, human ependymal cells are not well 'organized' but occupy the lumen, contrasting the regular pseudostratified, ciliated epithelium seen in rodents. However, in the human infant spinal cord ependymal cells are lining a fully open central canal, (Alfaro-Cervello et al. 2014; Milhorat et al. 1994 ). The central canal as observed here could be morphologically classified as ependymal rosette groups (Yasui et al. 1999; Milhorat et al. 1994) . This occluded central canal develops with aging but may occur as early as in the 20s (Milhorat et al. 1994; Kasantikul et al. 1979; Yasui et al. 1999; Garcia-Ovejero et al. 2015) . Furthermore, Alfaro-Cervello et al. (2014) have recently proposed that the stenosed adult human central canal is characterized by a hypocellular layer between ependymal cells, very much unlike the case in rodents. This new view is supported by an MRI study (Garcia-Ovejero et al. 2015) . Taken together, the important role of ependymal cells in ameliorating spinal cord injury in adult rodents may suggest that NECAB2 (and calretinin) in ependymal cells within the human central canal represent an interesting target for further studies of lesions at the spinal level.
